Edition:
Deutschland

Vaccinex Inc (VCNX.OQ)

VCNX.OQ on NASDAQ Stock Exchange Capital Market

2.06USD
19 Oct 2020
Change (% chg)

$0.08 (+4.04%)
Prev Close
$1.98
Open
$2.02
Day's High
$2.12
Day's Low
$1.99
Volume
179,041
Avg. Vol
174,102
52-wk High
$12.23
52-wk Low
$1.63

About

Vaccinex Inc. is a clinical-stage biotechnology company engaged in the discovery and development of targeted biotherapeutics. The Company is focused on providing treatments for serious diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. It provides SEMA4D antibody platform, which is focused on... (more)

Buy/Sell

Sell Hold Buy
2.00 Mean rating from 2 analysts

Overall

Beta: --
Market Cap(Mil.): $39.63
Shares Outstanding(Mil.): 20.02
Dividend: --
Yield (%): --

BRIEF-Vaccinex Provides Update Of Potentially Pivotal Signal Clinical Trial In Huntington's Disease

* VACCINEX PROVIDES UPDATE OF POTENTIALLY PIVOTAL SIGNAL CLINICAL TRIAL IN HUNTINGTON’S DISEASE

BRIEF-Vaccinex Reports First Quarter 2020 Financial Results And Provides Corporate Update

* VACCINEX REPORTS FIRST QUARTER 2020 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

Märkte

  • U.S.
  • Europa
  • Asien
  • Branchen

Branchenüberblick

Energie -0.06%
Rohstoffe -0.13%
Industrie -0.06%
Konjunktur abhängige Waren & Dienstleistungen -0.04%
Konjunktur unabhängige Waren & Dienstleistungen -0.10%
Finanzindustrie -0.04%
Pharma -0.01%
Technologie +0.00%

Nachrichten aus der Wirtschaft